tiprankstipranks
PremiumCompany AnnouncementsMetagenomi Reports Q3 Earnings and Strategic Progress
1M ago
Metagenomi reports Q3 EPS (51c), consensus (78c)
Premium
The Fly
Metagenomi reports Q3 EPS (51c), consensus (78c)
1M ago
Metagenomi presents poster on genome editing at ESGCT
Premium
The Fly
Metagenomi presents poster on genome editing at ESGCT
2M ago
Metagenomi reports Q1 EPS ($1.19), consensus ($2.04)
PremiumThe FlyMetagenomi reports Q1 EPS ($1.19), consensus ($2.04)
7M ago
Premium
Company Announcements
Metagenomi’s May 2024 Corporate Presentation Released
7M ago
Target upgraded, CVS downgraded: Wall Street’s top analyst calls
Premium
The Fly
Target upgraded, CVS downgraded: Wall Street’s top analyst calls
8M ago
Metagenomi price target lowered to $17 from $21 at ChardanModerna
PremiumThe FlyMetagenomi price target lowered to $17 from $21 at ChardanModerna
8M ago
Metagenomi downgraded to Neutral from Overweight at JPMorgan
Premium
The Fly
Metagenomi downgraded to Neutral from Overweight at JPMorgan
8M ago
Metagenomi regains full development rights to RIGS systems
Premium
The Fly
Metagenomi regains full development rights to RIGS systems
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100